In addition, subdividing tumours based on grade and clinical stage, two commonly used clinical classification systems, identified that PDCD1LG2 expression was significantly elevated in patients with PDAC tumours of advanced grade and clinical stage when compared with either early grade or stage tumours (Fig. 2b). Here, PDCD1LG2 is linked to neoplasm.